Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss	$ (6,980,947)	$ (8,772,866)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	12,999	14,180
Amortization of intangibles	49,320	49,663
Stock based compensation	1,467,426	1,499,302
Inventory Reserve	258,011	582,299
Employees paid in stock	417,500	317,265
Expense paid in stock	745,999	747,351
Unrealized gain on marketable securities	(9,282)	0
Bad debt expense	24,865	0
Amortization of right-of-use asset	88,450	80,533
Changes in operating assets and liabilities:
Decrease in accounts receivable	356,188	249,555
Increase in inventories	(1,103,861)	(833,121)
Increase in advances	(46,246)	(16,041)
Increase in prepaid expenses and other current assets	(73,912)	(68,512)
(Decrease) increase in accounts payable	(413,125)	322,300
(Decrease) increase in accounts payable, related party	(392,981)	407,636
Increase (decrease) in accrued expenses	386,882	(292,495)
(Decrease) in accrued expenses, related party	(30,361)	(246,692)
Decrease operating right of use lease asset	(83,054)	(72,353)
Net cash used in operating activities	(5,326,129)	(6,031,996)
Cash flows from investing activities:
Purchase of furniture, fixtures, and equipment	(4,881)	(8,527)
Sale of Marketable securities	4,966,213	0
Purchase of Marketable securities	(7,933,504)	0
Net cash provided by (used in) in investing activities	(2,972,172)	(8,527)
Cash flows from financing activities:
Net proceeds from issuance of Common Stock	2,570,101	0
Payments finance lease obligations	(9,366)	(8,544)
Net cash provided by (used in) financing activities	2,560,735	(8,544)
Net decrease in cash and cash equivalents	(5,737,566)	(6,049,067)
Cash and cash equivalents at beginning of period	8,715,279	14,764,346
Cash and cash equivalents at end of period	2,977,713	8,715,279
Supplemental non-cash disclosure of cash flow information:
Declared repurchase of noncontrolling interest	$ 214,000	$ 0